Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Immunol., 19 December 2025

Sec. Inflammation

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1765613

This article is part of the Research TopicCommunity Series in Crosstalk in Ferroptosis, Immunity & Inflammation: Volume IIView all 15 articles

Correction: Targeting ferroptosis: novel therapeutic approaches and intervention strategies for kidney diseases

  • 1Department of Nephrology, The Central Hospital of Shaoyang, Shaoyang, Hunan, China
  • 2Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China

A Correction on
Targeting ferroptosis: novel therapeutic approaches and intervention strategies for kidney diseases

By Luo Y, Long M, Wu X and Zeng L (2025) Front. Immunol. 16:1700004. doi: 10.3389/fimmu.2025.1700004

Author “Yanfang Luo and Xueqin Wu” was erroneously assigned to affiliation “Department of Nephrology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China”. This affiliation has now been removed for author “Yanfang Luo and Xueqin Wu”.

The Conflict of interest statement has been correct to “No changes to Conflict of interest: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest”.

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: ferropotosis, AKI, CKD, renal tumor, therapeutic translation, oxidative stress, iron metabolism

Citation: Luo Y, Long M, Wu X and Zeng L (2025) Correction: Targeting ferroptosis: novel therapeutic approaches and intervention strategies for kidney diseases. Front. Immunol. 16:1765613. doi: 10.3389/fimmu.2025.1765613

Received: 11 December 2025; Accepted: 16 December 2025; Revised: 12 December 2025;
Published: 19 December 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Luo, Long, Wu and Zeng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Xueqin Wu, Nzk5NTY1NjI2QHFxLmNvbQ==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.